Haleon PLC (HLN)
9.55
+0.07
(+0.74%)
USD |
NYSE |
Nov 21, 16:00
9.55
0.00 (0.00%)
After-Hours: 20:00
Haleon Enterprise Value: 53.38B for Nov. 20, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| November 20, 2024 | 53.38B |
| November 19, 2024 | 53.38B |
| November 18, 2024 | 53.15B |
| November 15, 2024 | 52.97B |
| November 14, 2024 | 52.61B |
| November 13, 2024 | 52.25B |
| November 12, 2024 | 52.47B |
| November 11, 2024 | 53.51B |
| November 08, 2024 | 53.96B |
| November 07, 2024 | 53.92B |
| November 06, 2024 | 53.65B |
| November 05, 2024 | 54.69B |
| November 04, 2024 | 54.64B |
| November 01, 2024 | 54.51B |
| October 31, 2024 | 54.33B |
| October 30, 2024 | 54.82B |
| October 29, 2024 | 55.28B |
| October 28, 2024 | 55.64B |
| October 25, 2024 | 55.05B |
| October 24, 2024 | 55.23B |
| October 23, 2024 | 55.28B |
| October 22, 2024 | 55.32B |
| October 21, 2024 | 55.64B |
| October 18, 2024 | 56.13B |
| October 17, 2024 | 56.09B |
| Date | Value |
|---|---|
| October 16, 2024 | 56.32B |
| October 15, 2024 | 55.82B |
| October 14, 2024 | 56.18B |
| October 11, 2024 | 55.95B |
| October 10, 2024 | 56.27B |
| October 09, 2024 | 56.04B |
| October 08, 2024 | 56.36B |
| October 07, 2024 | 55.86B |
| October 04, 2024 | 57.40B |
| October 03, 2024 | 57.54B |
| October 02, 2024 | 58.59B |
| October 01, 2024 | 59.28B |
| September 30, 2024 | 58.78B |
| September 27, 2024 | 59.08B |
| September 26, 2024 | 58.72B |
| September 25, 2024 | 58.72B |
| September 24, 2024 | 59.04B |
| September 23, 2024 | 58.90B |
| September 20, 2024 | 58.41B |
| September 19, 2024 | 58.14B |
| September 18, 2024 | 58.55B |
| September 17, 2024 | 59.01B |
| September 16, 2024 | 58.88B |
| September 13, 2024 | 58.38B |
| September 12, 2024 | 57.79B |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
36.78B
Minimum
Sep 02 2022
59.28B
Maximum
Oct 01 2024
48.95B
Average
49.40B
Median
Jun 07 2023
Enterprise Value Benchmarks
| Pfizer Inc | 198.27B |
| GSK PLC | 84.49B |
| Smith & Nephew PLC | 13.89B |
| Adaptimmune Therapeutics PLC | 33.86M |
| Biodexa Pharmaceuticals PLC | -3.674M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | 631.09M |
| Revenue (Quarterly) | 3.617B |
| Total Expenses (Quarterly) | 2.700B |
| EPS Diluted (Quarterly) | 0.1383 |
| Gross Profit Margin (Quarterly) | 62.88% |
| Profit Margin (Quarterly) | 17.45% |
| Earnings Yield | 3.54% |
| Operating Earnings Yield | 6.17% |
| Normalized Earnings Yield | 3.530 |